News
ENZ
1.130
-1.74%
-0.020
Weekly Report: what happened at ENZ last week (0408-0412)?
Weekly Report · 3d ago
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
PriceSmart, Inc. Posted better-than-expected earnings for its second quarter. The company reported quarterly sales of $1.29 billion. PriceSmart shares surged 4.6% to $86.90 in pre-market trading. Marin Software Incorporated shares rose 76.1% after the company announced upgrades to its Microsoft Corp advertising integration.
Benzinga · 04/10 12:12
Weekly Report: what happened at ENZ last week (0401-0405)?
Weekly Report · 04/08 09:28
Weekly Report: what happened at ENZ last week (0325-0329)?
Weekly Report · 04/01 09:28
Weekly Report: what happened at ENZ last week (0318-0322)?
Weekly Report · 03/25 09:29
Weekly Report: what happened at ENZ last week (0311-0315)?
Weekly Report · 03/18 09:28
Enzo Biochem Non-GAAP EPS of $0.00, revenue of $8.55M
Seeking Alpha · 03/13 20:54
*Enzo Biochem 2Q Loss $3.06M >ENZ
Dow Jones · 03/13 20:26
Press Release: Enzo Biochem Reports Second -2-
The company's net loss per share for the three and six months ended January 31, 2024 and 2023 is reported on a GAAP basis. The company has a net loss of $1.1 billion for the first quarter of 2024 and $2.1 million for the second quarter of 2023. A reconciliation of net income to adjusted net income (loss) is presented.
Dow Jones · 03/13 20:26
Press Release: Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update. The Company's Life Science division's second-quarter revenue of $8.5 million improved year-over-year by 14%. The Company ended the second quarter with aggregate cash and cash equivalents of $60.2 million. Enzo is a pioneer in molecular diagnostics.
Dow Jones · 03/13 20:26
*Enzo Biochem 2Q Rev $8.55M >ENZ
Dow Jones · 03/13 20:26
Enzo Biochem: Fiscal Q2 Earnings Snapshot
Enzo Biochem Inc. Reported a loss of $3.1 million in its fiscal second quarter. The life sciences and biotechnology company posted revenue of $8.6 million in the period. The Farmingdale, New York-based company said it lost 6 cents per share.
Barchart · 03/13 15:39
Weekly Report: what happened at ENZ last week (0304-0308)?
Weekly Report · 03/11 09:28
Weekly Report: what happened at ENZ last week (0226-0301)?
Weekly Report · 03/04 09:28
Enzo Biochem Executives Receive Raises and Equity Rewards
TipRanks · 02/27 21:28
Weekly Report: what happened at ENZ last week (0219-0223)?
Weekly Report · 02/26 09:31
Weekly Report: what happened at ENZ last week (0212-0216)?
Weekly Report · 02/19 09:31
Weekly Report: what happened at ENZ last week (0205-0209)?
Weekly Report · 02/12 09:28
Weekly Report: what happened at ENZ last week (0129-0202)?
Weekly Report · 02/05 09:31
Enzo Biochem Announces 2023 Annual Meeting Outcomes
TipRanks · 02/02 09:20
More
Webull provides a variety of real-time ENZ stock news. You can receive the latest news about Enzo Biochem Inc through multiple platforms. This information may help you make smarter investment decisions.
About ENZ
Enzo Biochem, Inc. is focused on molecular diagnostics and has a portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. The Company operates through the product segment, which manufactures, develops and markets products and tools for clinical research, translational research, drug development and bioscience research customers worldwide. The Company is engaged in product development and manufactures and supplies a comprehensive portfolio of products, including antibodies, genomic probes, assays, biochemicals and proteins. The Company's products and technologies are used in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry and small molecule chemistry. Its life science division supports the work of research centers and industry partners. It has built a portfolio of intellectual property assets, comprised of around 457 owned patents worldwide.